Article

Alimera dry eye emollient drop hits market

Alimera Sciences Inc. introduces its lubricant eye drops, Soothe Emollient, the first multi-dose, emollient-based artificial tear product for dry-eye sufferers.

Alimera Sciences Inc. introduces its lubricant eye drops, Soothe Emollient, the first multi-dose, emollient-based artificial tear product for dry-eye sufferers. The product is slated to reach U.S. retail stores by Sept. 15.

Using Restoryl, an advanced lipid restorative, Soothe re-establishes the eye's protective lipid layer to reduce tear evaporation and seal essential moisture, giving patients up to 8 hours of comfort.

Alimera Sciences licensed the artificial tear product in November 2003 from Ocular Research of Boston (ORB), a group of eye-care specialists who focus on dry eye research. The agreement combined the medical expertise of ORB with the ophthalmic commercial experience of Alimera Sciences.

"This product was inspired by and developed for dry eye patients," said Donald Korb, MD, ORB president, in a company statement. "Because Soothe restores the compromised lipid layer of patients' tears, regardless of the particular dry eye state, harmful evaporation is minimized and the ocular surface is protected.

"Thus, doctors can be confident that they are giving their patients long-lasting relief," Dr. Korb said. "After years of perfecting the formula and finding the right partner, I am excited that Soothe will be accessible to patients in such a short time."

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) 50 years of ophthalmology: What changed the game? (Part 1)
(Image credit: Ophthalmology Times) From MIGS to gene therapy: Inder Paul Singh, MD, celebrates the past and future of glaucoma care
(Image credit: Ophthalmology Times) NeuroOp Guru: Using OCT to forecast outcomes in ethambutol optic neuropathy
(Image credit: Ophthalmology Times) Inside NYEE’s new refractive solutions center with Kira Manusis, MD
(Image credit: Ophthalmology Times) Dilsher Dhoot, MD, on the evolution of geographic atrophy therapy: where are we now?
(Image credit: Ophthalmology Times Europe) Anat Loewenstein, MD, shares insights on the real-world results of remote retinal imaging
(Image credit: Ophthalmology Times) Two-wavelength autofluorescence for macular xanthophyll carotenoids with Christine Curcio, PhD
(Image credit: Ophthalmology Times) FLIO and the brain: Making the invisible visible with Robert Sergott, MD
(Image credit: Ophthalmology Times) Structure-function correlates using high-res OCT images with Karl Csaky, MD, PhD
© 2025 MJH Life Sciences

All rights reserved.